{"id":"W2960195497","doi":"10.1016/j.jchf.2019.05.015","title":"Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction","year":2019,"lang":"en","type":"article","venue":"JACC Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Janssen Pharmaceuticals; National Heart, Lung, and Blood Institute; National Medical Research Council; Baxter Healthcare Corporation; GE Healthcare; National Center for Advancing Translational Sciences; Johnson and Johnson; Gilead Sciences; Servier; MyoKardia; Novo Nordisk; Seventh Framework Programme; Daiichi-Sankyo; Bayer Fund; Cytokinetics; Boston Scientific Corporation; Agence Nationale de la Recherche; Roche; Novartis; European Commission; Sanofi; Merck; GlaxoSmithKline; Boehringer Ingelheim; Amgen; Vifor Pharma; Pfizer; Bristol-Myers Squibb; AstraZeneca; National Institutes of Health; Medtronic","keywords":"Medicine; Heart failure; Valsartan; Ejection fraction; Clinical trial; Randomization; Internal medicine; Heart failure with preserved ejection fraction; Quality of life (healthcare); Sacubitril; Cardiology; Blood pressure","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001003402,0.0002979888,0.00113102,0.0003502223,0.00007475556,0.00002497454,0.00007538467,0.0002553659,0.0009988341],"category_scores_gemma":[0.0001205647,0.0002413452,0.0001802904,0.0007463756,0.0000503956,0.0003536256,0.00005007679,0.0005123672,0.0004335852],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002626571,"about_ca_system_score_gemma":0.0003380091,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004664139,"about_ca_topic_score_gemma":0.003552349,"domain_scores_codex":[0.9970301,0.0003605055,0.0009379257,0.0005573708,0.0006092419,0.0005048399],"domain_scores_gemma":[0.9984696,0.0001278805,0.000265614,0.0006892764,0.000154008,0.0002936112],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006901193,0.0005540308,0.8982909,0.0006319308,0.0001518984,0.000004307372,0.0001598938,0.00008155084,0.003520007,0.000193841,0.09558377,0.0001377583],"study_design_scores_gemma":[0.006641998,0.001360616,0.7060128,0.0004973062,0.00004793255,0.00002059011,0.001142621,0.0001660335,0.0006787446,0.00004552381,0.2831039,0.0002818638],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8740245,0.0001504891,0.00005454004,0.1228545,0.0001263037,0.002160462,0.000006597076,0.000151047,0.0004715795],"genre_scores_gemma":[0.9873131,0.00001113371,0.009826152,0.001057582,0.00008176418,0.00007802426,0.0001016713,0.00004489173,0.001485661],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1922781,"threshold_uncertainty_score":0.9999144,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02481825569405591,"score_gpt":0.2975866812743614,"score_spread":0.2727684255803055,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}